The Surrogacy Center at the Clinic of Prof. Feskova A.M. has been operating since 2006, offering a comprehensive range of services, including surrogate mother selection, assisted reproductive technology programs, pregnancy management, childbirth organization, and legal support.
6 July 2015Clinical trials for the drug "REVATION" are scheduled to take place at Kyiv City Clinical Hospital No. 5. The study involves a 5-year duration, and eligible patients can participate based on specific criteria established by the manufacturer.
3 March 2015On September 23, 2014, the Public Council under the Ministry of Health of Ukraine welcomed the Association of Patients with Pulmonary Hypertension in Ukraine, led by the Chairman of the Board, Oksana Alexandrova, as a new member.
30 October 2014Colleagues from the Greek Association of Pulmonary Hypertension Patients have extended an invitation for us to participate in a flash mob on their Facebook page. The #selfoeforPH flash mob, centered around taking selfies, is gaining momentum, with Ukrainian patients showcasing photos featuring…
30 October 2014On March 25, 2014, we participated in the signing of a memorandum initiating a bill in the Verkhovna Rada of Ukraine. The bill aimed to raise excise taxes on alcohol and tobacco, directing 100% of the funds towards purchasing medicines for patients in Ukraine.
27 August 2014On April 15, 2014, the Verkhovna Rada of Ukraine passed the Law of Ukraine “On Amendments to the Fundamentals of Ukrainian Legislation on Health Care to Ensure the Prevention and Treatment of Rare (Orphan) Diseases” with 260 votes (registration No. 2461). The initiative was led by the parliamentary…
16 April 2014Dear participants of the Ukrainian Association of Pulmonary Hypertension! In the near future, please do not forget to contact your local therapists and cardiologists, your treating (disease) doctors at your place of residence (registration), in order to complete and submit an application to receive…
21 February 2014In mid-June 2013, the Association addressed the Minister of Health of Ukraine, R.V. Bogatyreva, and the Chairman of the Verkhovna Rada Committee on Health Issues, T.D. Bakhteeva, with the following letters
18 July 2013The pharmaceutical company Bayer is gearing up to launch a highly effective drug for the treatment of pulmonary arterial hypertension into the market by mid-14, with plans for free sale. Clinical trials for the new drug, Riociguat, have commenced in humans and are showing promising results.
13 December 2012